Keyword search (4,163 papers available)

"Lu H" Authored Publications:

Title Authors PubMed ID
1 Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles antifungal activities Li W; Whiteway M; Hang S; Yu J; Lu H; Jiang Y; 40707518
BIOLOGY
2 Otilonium Bromide Exhibits Potent Antifungal Effects by Blocking Ergosterol Plasma Membrane Localization and Triggering Cytotoxic Autophagy in Candida Albicans Zhen C; Wang L; Feng Y; Whiteway M; Hang S; Yu J; Lu H; Jiang Y; 38995235
BIOLOGY
3 Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species Li W; Feng Y; Feng Z; Wang L; Whiteway M; Lu H; Jiang Y; 38929106
BIOLOGY
4 Understanding Fluconazole Tolerance in Candida albicans: Implications for Effective Treatment of Candidiasis and Combating Invasive Fungal Infections Feng Y; Lu H; Whiteway M; Jiang Y; 37918789
BIOLOGY
5 Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies Lu H; Hong T; Jiang Y; Whiteway M; Zhang S; 37307922
BIOLOGY
6 A Small Molecule Inhibitor of Erg251 Makes Fluconazole Fungicidal by Inhibiting the Synthesis of the 14α-Methylsterols Lu H; Li W; Whiteway M; Wang H; Zhu S; Ji Z; Feng Y; Yan L; Fang T; Li L; Ni T; Zhang X; Lv Q; Ding Z; Qiu L; Zhang D; Jiang Y; 36475771
BIOLOGY
7 Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target Li W; Shrivastava M; Lu H; Jiang Y; 33989979
BIOLOGY
8 Candida albicans targets that potentially synergize with fluconazole. Lu H, Shrivastava M, Whiteway M, Jiang Y 33587857
BIOLOGY

 

Title:Understanding Fluconazole Tolerance in Candida albicans: Implications for Effective Treatment of Candidiasis and Combating Invasive Fungal Infections
Authors:Feng YLu HWhiteway MJiang Y
Link:https://pubmed.ncbi.nlm.nih.gov/37918789/
DOI:10.1016/j.jgar.2023.10.019
Publication:Journal of global antimicrobial resistance
Keywords:Candida albicansFluconazole synergistic lethal adjuvantsFluconazole synergistic lethal targetsFluconazole toleranceInvasive fungal disease
PMID:37918789 Category: Date Added:2023-11-03
Dept Affiliation: BIOLOGY
1 Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
2 Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: luhui2019@tongji.edu.cn.
3 Department of Biology, Concordia University, Montreal, QC, Canada. Electronic address: malcolm.whiteway@concordia.ca.
4 Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: 19851@tongji.edu.cn.

Description:

Fluconazole (FLC) tolerant phenotypes in Candida species contribute to persistent candidemia and the emergence of FLC resistance. Therefore, making FLC fungicidal and eliminating FLC tolerance are important for treating invasive fungal diseases (IFDs) caused by Candida species. However, the mechanisms of FLC tolerance in Candida species remain to be fully explored. This review discusses the high incidence of FLC tolerance in Candida species and the importance of successfully clearing FLC tolerance in treating candidiasis. We further define and characterize FLC tolerance in C. albicans and suggest that FLC tolerance is a strategy of C. albicans response to FLC damage whose mechanism differs from FLC resistance. This review identifies global factors affecting FLC tolerance and highlights the significance of the cell membrane and cell wall integrity in FLC tolerance, guiding approaches to combat IFDs caused by Candida species.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University